注射用人免疫球蛋白临床应用研究现状  

Research progress in clinical application of human immunoglobulin for injection

作　　者：程梁华 彭莉 伍晓晓 贾艳艳 CHENG Liang-hua;PENG Li;WU Xiao-xiao;JIA Yan-yan(Department of Pharmacy,First Affiliated Hospital of Air Force Military Medical University of Chinese People’s Liberation Army,Xi'an 710000,Shaanxi Province,China)

机构地区：[1]中国人民解放军空军军医大学第一附属医院药剂科,陕西西安710000

出　　处：《中国临床药理学杂志》2021年第16期2238-2241,共4页The Chinese Journal of Clinical Pharmacology

基　　金：陕西省重点研发计划基金资助项目(S2020-YF-ZDCXL-ZDLSF-0183)。

摘　　要：静脉注射用人免疫球蛋白(IVIG)是从健康人血浆中分离制得的广谱抗毒素免疫球蛋白制剂。在临床应用较为广泛,本文从免疫缺陷病、血液系统疾病、感染性疾病、呼吸系统疾病、皮肤病、神经系统疾病、结缔组织病和泌尿系统疾病几个方面对其临床应用进行了总结分类。清晰展示了IVIG在不同疾病的临床应用现状。Human immunoglobulin for intravenous injection is a broad-spectrum antitoxin immunoglobulin preparation isolated from healthy human plasma.It has a wide range of clinical applications.This article summarizes and categorizes its clinical applications from several aspects:immunodeficiency,blood system disease,infectious disease,respiratory system disease,skin disease,nervous system disease,connective tissue disease,and urinary system disease.It clearly shows the clinical application status of IVIG in different diseases.

关 键 词：静脉注射用人免疫球蛋白 临床应用 免疫缺陷 免疫调节 

分 类 号：R95[医药卫生—药学]